Market Overview

Aimmune Therapeutics Shareholder Enright Buys 312,500 Shares @$16.00/Share -Form 4

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Offerings Insider Trades IPOs

 

Related Articles (AIMT)